Molecular based methods have advanced the centre testing to faster and better diagnostics. PCR methods, microarray and next generation sequencing have provided speed and
high level of accuracy. Molecular biology based methods are sensitive and quick to detect microbial pathogens in various clinical specimens.
We offer molecular detection of pathogenic viruses, bacteria and parasites from clinical specimens. MBG is ISO 15189 accredited and benefits from a stand-alone
containment Level 3 facility where samples for highly contagious pathogen are received and processed.
Chikungunya virus is most often spread to people by Aedes aegypti and Aedes albopictus mosquitoes. It is rarely transmitted from mother to newborn around the time of birth. Prior to 2013, Chikungunya virus cases and outbreaks had been identified in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories. Local transmission means that mosquitoes in the area have been infected with the virus and are spreading it to people. Symptoms usually begin 3-7 days after being bitten by an infected mosquito. The most common symptoms of infection are fever and joint pain. Other symptoms may include headache, muscle pain, joint swelling or rash. There is no vaccine to prevent or medicine to treat chikungunya virus infection. Travelers can protect themselves by preventing mosquito bites. During the first 8 days of illness, chikungunya viral RNA can often be identified in serum.
Dengue viruses are spread to people through the bite of an infected Aedes species (Ae. aegypti or Ae. albopictus) mosquito. A pregnant woman already infected with dengue can pass the virus to her fetus during pregnancy or around the time of birth. Dengue has emerged as a worldwide problem since the 1960s. The disease is common in many popular tourist destinations in the Caribbean (including Puerto Rico), Central and South America, Southeast Asia, and the Pacific Islands. Mild symptoms of dengue can be confused with other illnesses that cause fever, aches and pains, or a rash. The most common symptom of dengue is fever with any of the following: nausea, vomiting, rash, aches and pains (eye pain, typically behind the eyes, muscle, joint, or bone pain). Most people will recover after about a week. There is no specific medication to treat dengue. A blood test is the only way to confirm the diagnosis.
Pathogens Tested
Chikungunya
Dengue Virus
Method
Real-Time RT-PCR.
Sample Type
EDTA blood, Serum
Transport Condition
Samples should be transported at 4°C.
Turn Around Time (TAT)
TAT for routine samples is within 3 working days. Samples delivered after 11:00 AM will be processed next working day (unless urgent).
Urgent Samples will be reported within 24-48 hours and will be charged double.
Molecular based methods have advanced the centre testing to faster and better diagnostics. PCR methods, microarray and next generation sequencing have provided speed and
high level of accuracy. Molecular biology based methods are sensitive and quick to detect microbial pathogens in various clinical specimens.
We offer molecular detection of pathogenic viruses, bacteria and parasites from clinical specimens. MBG is ISO 15189 accredited and benefits from a stand-alone
containment Level 3 facility where samples for highly contagious pathogen are received and processed.
Chikungunya virus is most often spread to people by Aedes aegypti and Aedes albopictus mosquitoes. It is rarely transmitted from mother to newborn around the time of birth. Prior to 2013, Chikungunya virus cases and outbreaks had been identified in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories. Local transmission means that mosquitoes in the area have been infected with the virus and are spreading it to people. Symptoms usually begin 3-7 days after being bitten by an infected mosquito. The most common symptoms of infection are fever and joint pain. Other symptoms may include headache, muscle pain, joint swelling or rash. There is no vaccine to prevent or medicine to treat chikungunya virus infection. Travelers can protect themselves by preventing mosquito bites. During the first 8 days of illness, chikungunya viral RNA can often be identified in serum.
Dengue viruses are spread to people through the bite of an infected Aedes species (Ae. aegypti or Ae. albopictus) mosquito. A pregnant woman already infected with dengue can pass the virus to her fetus during pregnancy or around the time of birth. Dengue has emerged as a worldwide problem since the 1960s. The disease is common in many popular tourist destinations in the Caribbean (including Puerto Rico), Central and South America, Southeast Asia, and the Pacific Islands. Mild symptoms of dengue can be confused with other illnesses that cause fever, aches and pains, or a rash. The most common symptom of dengue is fever with any of the following: nausea, vomiting, rash, aches and pains (eye pain, typically behind the eyes, muscle, joint, or bone pain). Most people will recover after about a week. There is no specific medication to treat dengue. A blood test is the only way to confirm the diagnosis.
Pathogens Tested
Chikungunya
Dengue Virus
Method
Real-Time RT-PCR.
Sample Type
EDTA blood, Serum
Transport Condition
Samples should be transported at 4°C.
Turn Around Time (TAT)
TAT for routine samples is within 3 working days. Samples delivered after 11:00 AM will be processed next working day (unless urgent).
Urgent Samples will be reported within 24-48 hours and will be charged double.
